GP531 T13713
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GP531 is a second-generation adenosine regulating agent. It�is pharmacologically silent under basal conditions but increases localized endogenous adenosine during ischemia.
CAS nr:
142344-87-4
Purity:
98%
Molecular Weight:
347,37
SMILES:
O=C(C1=C(N)N([C@H]2[C@@H]([C@@H]([C@@H](CNCC3=CC=CC=C3)O2)O)O)C=N1)N
Formula:
C16H21N5O4
Pathway:
Neuroscience
Target:
AChR
